Li Li

Company: Apellis Pharmaceuticals

Job title: Senior Medical Director

Seminars:

Leveraging the Power of the Complement System to Target Glomerular Disease Pathophysiology 2:00 pm

Understand how dysregulation of the complement system contributes to the pathogenesis of C3 Glomerulopathy (C3G) and Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN), highlighting the role of C3 inhibition in addressing these complement-driven kidney diseases. Explore the latest developments in targeting complement activity, focusing on emerging therapies that aim to reduce immune-mediated kidney damage and improve outcomes…Read more

day: Pre-Conference Focus Day

Panel Discussion & Audience Roundtable: Advancing Therapeutics in Glomerular Diseases: What’s Next? 2:30 pm

Discuss the need to identify reliable surrogate markers for other glomerular diseases and potential avenues for development and standardization Discuss what can be learned from the established biomarkers in IgA nephropathy to improve patient outcomes in other glomerular diseases Examine the variability in pathology and clinical presentation among glomerular disease patients, and what strategies can…Read more

day: Pre-Conference Focus Day